AP-NORC Poll: Half of Americans Would Get a COVID-19 Vaccine
Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed. Another 31% simply aren't sure, ...Actualités similaires
Articles similaires à AP-NORC Poll: Half of Americans Would Get a COVID-19 Vaccine
WHO Chief: World on Brink of Moral Failure' Over COVID-19 Vaccine Distribution
Tedros urges wealthier nations to share COVID-19 vaccines with poorer countriesActualités similaires
EU Doubles Doses of Pfizer/BioNTech COVID-19 Vaccine
Along with Moderna contract, EU says it will have enough to vaccinate 380 million peopleActualités similaires
China Grants First Approval of Homegrown COVID-19 Vaccine
Vaccine developed by state-run Sinopharm granted conditional approval after drugmaker said it was 79% effective against virusActualités similaires
France, Romania Receive First Doses of Pfizer BioNTech COVID-19 Vaccine
Russia approves its main coronavirus vaccine for people over 60 years oldActualités similaires
Halal Status of COVID-19 Vaccine Worries Muslims
Pork-derived gelatin has been widely used as a stabilizer in vaccinesActualités similaires
WHO: Equitable, Global Distribution of 2 Billion COVID-19 Vaccine Doses to Begin in 2021
Funding shortfall could stop COVAX effort to bring vaccines to poorest nationsPence to Get COVID-19 Vaccine on Live TV
Live inoculations come after reports of American skepticism about the vaccineActualités similaires
US Nears Emergency Approval of Second COVID-19 Vaccine
US Food and Drug Administration affirms data that Moderna vaccine is safe and effectiveActualités similaires
Philippines Targets Deal for 25 MLN Doses of Sinovac COVID-19 Vaccine
The Philippines aims to finalize negotiations with Sinovac Biotech this week to acquire 25 million doses of the Chinese company's COVID-19 vaccine for delivery ...Actualités similaires
Americans Await Final Approval of First COVID-19 Vaccine as Deaths Reach Record High
US Food and Drug Administration widely expected to authorize emergency use after special panel votes to recommend approval//Countdown Begins for Final US Approval of First COVID-19 Vaccine
US Food and Drug Administration widely expected to authorize emergency use after a special panel votes to recommend vaccine's approval//Actualités similaires
US Panel Recommends Approval of First COVID-19 Vaccine/
Special advisory committee of US Food and Drug Administration voted Thursday for the emergency approval of the Pfizer/BioNTech COVID-19 vaccine//Actualités similaires
FDA Panel Recommends Approval of First COVID-19 Vaccine
Special advisory committee of US Food and Drug Administration voted Thursday for the emergency approval of the Pfizer/BioNTech COVID-19 vaccine//Actualités similaires
US Nearing Approval of First COVID-19 Vaccine
Special advisory committee of US Food and Drug Administration meets Thursday to consider Pfizer/BioNTech vaccine/Actualités similaires
Britain Grants Emergency Approval of New COVID-19 Vaccine/Developed by U.S.-Based Pfizer and Germany's BioNTech
'Historic moment' makes Britain first Western nation preparing to begin mass inoculations against novel coronavirusActualités similaires
Millions of Americans Travel for Thanksgiving Despite COVID-19 Warnings
Travelers dismiss warnings despite surge in COVID-19 deathsActualités similaires
Dow Closes at Record on News of Second Potential COVID-19 Vaccine
Investors cheered by Moderna's announcement of 95% effectiveness rate of experimental vaccineActualités similaires
European Markets Soar on News of Second Potential COVID-19 Vaccine
Investors buoyed by encouraging economic data from Japan and ChinaActualités similaires
The Infodemic: Pfizer COVID-19 Vaccine Wasn't Part of 'Warp Speed' Program
Fake news about the coronavirus can do real harm. Polygraph.info is spotlighting fact-checks from other reliable sources here .Actualités similaires
Peru Set to Host Phase 3 of COVID-19 Vaccine Clinical Trials
Peru is seeking 3,500 participants in the multinational studyActualités similaires
European Financial Markets Reap Gains Sparked by Hopes of Potential COVID-19 Vaccine
Europe's benchmark indices were higher due to rising optimism over US drugmaker Pfizer's potential COVID-19 vaccineActualités similaires
Brazil Suspends Trials of COVID-19 Vaccine in its Final Trials Before Possible Approval
Brazil suspends trials of Chinese developed coronavirus vaccine after an adverse incident involving a volunteerActualités similaires
Kenya Launches Human Trials of COVID-19 Vaccine
Amid calls for vaccine equity, Kenya joins global search for COVID cure/Actualités similaires
Back at White House, Trump Urges Americans 'Don't Be Afraid' of COVID-19
Lead physician tells reporters president may not entirely be out of the woods yet'Back at White House, Trump Tells Americans 'Don't Be Afraid' of COVID-19
Lead physician tells reporters president may not entirely be out of the woods yet'• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
